|
Press Releases |
|
 |
|
Tuesday, October 24, 2017 |
|
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar |
SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market. more info >> |
|
Tuesday, August 15, 2017 |
|
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances |
Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications. more info >> |
|
Thursday, June 15, 2017 |
|
First-Year Performance of Global Systematic Multi-Strategy Fund |
The Board of Directors of Singapore eDevelopment Ltd ("SeD") wishes to announce that its Global Systematic Multi-Strategy Fund ("GSMS Fund") managed by Hengfai Asset Management Pte Ltd ("HFAM"), a wholly owned subsidiary of SeD's investment-arm SeD Capital Pte Ltd, achieved a gross and net return of 15% and 10%, respectively, in its first year of operation. more info >> |
|
Monday, May 22, 2017 |
|
Singapore eDevelopment's Global BioLife Initiates Research on New Universal Drug Platform |
Singapore eDevelopment Ltd ("SeD"), through its subsidiary Global BioLife Inc. ("Global BioLife"), has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. The research will be led by two-time Nobel Prize nominee, Mr Daryl Thompson. more info >> |
|
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform |
Singapore eDevelopment Limited ("SeD") subsidiary Global BioLife Inc. has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
富途私人財富中心(Private Wealth Management)聯合中國碳中和发展集团(HK.1372) 成功舉辦零碳徒步活動
May 27, 2023 10:07 HKT/SGT
|
|
|
A Bigger InfoComm Asia 2023 Set to Inspire Digital Transformation
May 27, 2023 00:05 HKT/SGT
|
|
|
Chic Hong Kong Grand Opening at COCO Park Shenzhen
May 26, 2023 22:00: JST
|
|
|
Chic Hong Kong Grand Opening at COCO Park Shenzhen
May 26, 2023 21:00 HKT/SGT
|
|
|
Vivid Sydney 2023 Lights Up Its Greatest Festival Yet
May 26, 2023 19:45 HKT/SGT
|
|
|
Vivid Sydney 2023 Lights Up Its Greatest Festival Yet
May 26, 2023 19:45 HKT/SGT
|
|
|
Imposing island challenge awaits TOYOTA GAZOO Racing
May 26, 2023 17:35 JST
|
|
|
Results of a Collision Test Conducted on the Driver's Side of a Toyota RAIZE
May 26, 2023 15:07 JST
|
|
|
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
May 26, 2023 14:15 JST
|
|
|
6th Edition of Global CX Summit, Mumbai; Physical Conference on July 6, 2023
May 26, 2023 11:48: JST
|
|
|
Honda、ロードスポーツモデル「GB350」「GB350 S」の仕様を一部変更し発売
May 26, 2023 11:30: JST
|
|
|
磷酸鐵鋰王者再領潮流,國軒高科發佈重磅新品
May 26, 2023 11:25 HKT/SGT
|
|
|
磷酸铁锂王者再领潮流,国轩高科发布重磅新品
May 26, 2023 11:24 HKT/SGT
|
|
|
富士通、「Fujitsu Technology and Service Vision 2023」を策定
May 26, 2023 11:00: JST
|
|
|
6th Edition of Global CX Summit, Mumbai; Physical Conference on July 6, 2023
May 26, 2023 10:48 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|